Myocardial Solutions Inc

Myocardial Solutions, Inc. (MSI) is a medical technology company based in Morrisville, North Carolina. Employing 36 people, MSI generates approximately $5.8 million in annual revenue. The company focuses on developing innovative solutions for cardiac and cancer care. MSI's flagship product, MyoStrain®, is a non-invasive heart function test designed to detect and measure cardiotoxicity, a common side effect of cancer treatments. This 10-minute test utilizes high-speed MR imaging to provide physicians with sensitive diagnostic markers, enabling early assessment and individualized treatment of heart dysfunction. MyoStrain helps physicians holistically evaluate and protect patient heart health without interrupting oncology care. MyoStrain quantifies segmental strain across 48 segments of the heart, generating a comprehensive report and the MyoHealth™ Score. This single-number indicator helps physicians assess patient heart health and manage cardio-protection over time. The test has received FDA-510(k) pre-market clearance, CE-mark certification, and is available in both the United States and Europe. For more information about MSI and MyoStrain®, please visit myocardialsolutions.com.